Breast screening programme started in Spain:
This article was originally published in Clinica
Executive Summary
Insalud, the Spanish health agency, has signed an agreement with the Spanish Association Against Cancer (AECC) to set up a two-year screening programme for breast cancer in women aged between 50 and 64. The mammograms will be carried out by AECC clinics and mobile units and anyone who is suspected of having cancer will then be sent to Insalud hospitals to undergo further tests. By freeing its machines from the initial screening phase, Insalud, which provides healthcare for the regions that have not yet become autonomous, hopes to reduce the waiting time for breast cancer diagnosis. Breast cancer is the primary cause of cancer deaths in Spanish women.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.